P
Procaps Group, S.A. (“Procaps”) is a leading developer of pharmaceutical and nutraceutical solutions, medicines, and hospital supplies that reach more than 50 countries in all five continents. Procaps has a direct presence in 13 countries in the Americas and more than 5.500 employees working under a sustainable model. Procaps develops, manufactures, and markets over-the-counter (OTC) pharmaceutical products, prescription pharmaceutical drugs (Rx), nutritional supplements, and high-potency clinical solutions.
Investor insights
Funding rounds participated in
$40M sweet spot round size
Investor type
Public Company
Basic info
Industry
Pharmaceutical Manufacturing
Sectors
Pharmaceutical Manufacturing
Funding rounds raised
Total raised
$40M
from 1 investors over 1 rounds
P
Procaps Group raised $40M on December 29, 2024
Investors: Hoche Partners